Globus Medical SG&A Expenses 2010-2024 | GMED

Globus Medical annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Globus Medical sg&a expenses for the quarter ending December 31, 2024 were $0.253B, a 3.58% increase year-over-year.
  • Globus Medical sg&a expenses for the twelve months ending December 31, 2024 were $0.981B, a 52.48% increase year-over-year.
  • Globus Medical annual sg&a expenses for 2024 were $0.981B, a 52.48% increase from 2023.
  • Globus Medical annual sg&a expenses for 2023 were $0.643B, a 48.9% increase from 2022.
  • Globus Medical annual sg&a expenses for 2022 were $0.432B, a 5.87% increase from 2021.
Globus Medical Annual SG&A Expenses
(Millions of US $)
2024 $981
2023 $643
2022 $432
2021 $408
2020 $355
2019 $355
2018 $312
2017 $268
2016 $222
2015 $210
2014 $189
2013 $183
2012 $169
2011 $140
2010 $123
2009 $108
Globus Medical Quarterly SG&A Expenses
(Millions of US $)
2024-12-31 $253
2024-09-30 $241
2024-06-30 $238
2024-03-31 $249
2023-12-31 $245
2023-09-30 $156
2023-06-30 $120
2023-03-31 $122
2022-12-31 $118
2022-09-30 $107
2022-06-30 $107
2022-03-31 $101
2021-12-31 $107
2021-09-30 $96
2021-06-30 $107
2021-03-31 $98
2020-12-31 $92
2020-09-30 $89
2020-06-30 $80
2020-03-31 $94
2019-12-31 $92
2019-09-30 $88
2019-06-30 $88
2019-03-31 $86
2018-12-31 $84
2018-09-30 $75
2018-06-30 $77
2018-03-31 $76
2017-12-31 $73
2017-09-30 $63
2017-06-30 $64
2017-03-31 $67
2016-12-31 $61
2016-09-30 $54
2016-06-30 $53
2016-03-31 $54
2015-12-31 $51
2015-09-30 $52
2015-06-30 $55
2015-03-31 $52
2014-12-31 $49
2014-09-30 $47
2014-06-30 $46
2014-03-31 $47
2013-12-31 $46
2013-09-30 $46
2013-06-30 $46
2013-03-31 $45
2012-12-31 $45
2012-09-30 $42
2012-06-30 $41
2012-03-31 $41
2011-12-31 $39
2011-09-30 $35
2011-06-30 $34
2011-03-31 $34
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.948B $2.519B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $184.546B 80.83
Thermo Fisher Scientific (TMO) United States $161.389B 19.52
Alcon (ALC) Switzerland $47.559B 31.61
Edwards Lifesciences (EW) United States $44.842B 29.34
IDEXX Laboratories (IDXX) United States $35.412B 40.95
DexCom (DXCM) United States $27.957B 43.21
IQVIA Holdings (IQV) United States $27.056B 14.97
Mettler-Toledo (MTD) United States $22.200B 25.88
STERIS (STE) Ireland $22.012B 25.17
Waters (WAT) United States $20.277B 28.71
SONOVA HOLDING (SONVY) Switzerland $18.073B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.659B 14.96
Hologic (HOLX) United States $13.095B 14.13
Sysmex ADR (SSMXY) Japan $11.834B 0.00
Penumbra (PEN) United States $11.498B 90.25
Masimo (MASI) United States $8.815B 36.99
Teleflex (TFX) United States $6.409B 9.87
Glaukos (GKOS) United States $5.356B 0.00
Integer Holdings (ITGR) United States $4.429B 23.20
TransMedics (TMDX) United States $3.126B 91.51
PROCEPT BioRobotics (PRCT) United States $3.115B 0.00
Veracyte (VCYT) United States $2.446B 44.20
Nihon Kohden (NHNKY) Japan $2.137B 11.68
LivaNova (LIVN) United Kingdom $2.047B 12.43
Elekta AB (EKTAY) Sweden $1.922B 17.28
Alphatec Holdings (ATEC) United States $1.638B 0.00
Integra LifeSciences Holdings (IART) United States $1.340B 6.78
Pulse Biosciences (PLSE) United States $1.197B 0.00
Tandem Diabetes Care (TNDM) United States $1.116B 0.00
Artivion (AORT) United States $1.024B 95.96
OPKO Health (OPK) United States $0.940B 0.00
AxoGen (AXGN) United States $0.732B 0.00
IRadimed (IRMD) United States $0.683B 35.80
Mesa Laboratories (MLAB) United States $0.638B 13.94
RxSight (RXST) United States $0.619B 0.00
SiBone (SIBN) United States $0.607B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.585B 9.41
ORTHOFIX MEDICAL INC (OFIX) United States $0.551B 0.00
OrthoPediatrics (KIDS) United States $0.523B 0.00
Beta Bionics (BBNX) United States $0.476B 0.00
Treace Medical Concepts (TMCI) United States $0.443B 0.00
ClearPoint Neuro (CLPT) United States $0.410B 0.00
Delcath Systems (DCTH) United States $0.408B 0.00
NeuroPace (NPCE) United States $0.392B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
Tactile Systems Technology (TCMD) United States $0.337B 18.00
Pacific Biosciences Of California (PACB) United States $0.333B 0.00
Semler Scientific (SMLR) United States $0.326B 6.92
Neuronetics (STIM) United States $0.292B 0.00
Anteris Technologies Global (AVR) Australia $0.198B 0.00
Inogen (INGN) United States $0.196B 0.00
908 Devices (MASS) United States $0.196B 0.00
CVRx (CVRX) United States $0.193B 0.00
Alpha Tau Medical (DRTS) Israel $0.191B 0.00
Accuray (ARAY) United States $0.167B 0.00
LENSAR (LNSR) United States $0.166B 0.00
Sight Sciences (SGHT) United States $0.163B 0.00
Spectral Diagnostics (EDTXF) Canada $0.163B 0.00
Lucid Diagnostics (LUCD) United States $0.133B 0.00
KORU Medical Systems (KRMD) United States $0.121B 0.00
Atossa Genetics (ATOS) United States $0.103B 0.00
Monogram Orthopaedics (MGRM) United States $0.102B 0.00
Rapid Micro Biosystems (RPID) United States $0.102B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
InspireMD (NSPR) Israel $0.075B 0.00
Sensus Healthcare (SRTS) United States $0.073B 11.12
Hyperfine (HYPR) United States $0.057B 0.00
Zomedica (ZOMDF) United States $0.056B 0.00
EnVVeno Medical (NVNO) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.051B 0.00
Baird Medical Investment Holdings (BDMD) $0.040B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
NexGel (NXGL) United States $0.019B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00